Gene · 64005
Papers2,247
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,247
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. | Vaccines (Basel) | 2022 | 36679895 | PubTator, text mining | PubMed |
| Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies. | Pathogens | 2022 | 36678399 | PubTator, text mining | PubMed |
| Antiviral Activities of Ethyl Pheophorbides a and b Isolated from Aster pseudoglehnii against Influenza Viruses. | Molecules | 2022 | 36615236 | PubTator, text mining | PubMed |
| Influence of the solvent in the self-assembly and binding properties of [1 + 1] tetra-imine bis-calix[4]pyrrole cages. | Chem Sci | 2022 | 36605742 | PubTator, text mining | PubMed |
| Evaluation of dendritic cell-targeting T7 phages as a vehicle to deliver avian influenza virus H5 DNA vaccine in SPF chickens. | Front Immunol | 2022 | 36591272 | PubTator, text mining | PubMed |
| Rat and fish peripheral blood leukocytes respond distinctively to Anisakis pegreffii (Nematoda, Anisakidae) crude extract. | Front Cell Infect Microbiol | 2022 | 36590595 | PubTator, text mining | PubMed |
| Breathing and Tilting: Mesoscale Simulations Illuminate Influenza Glycoprotein Vulnerabilities. | ACS Cent Sci | 2022 | 36589893 | PubTator, text mining | PubMed |
| Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice. | Vaccines (Basel) | 2022 | 36560540 | PubTator, text mining | PubMed |
| Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines. | Vaccines (Basel) | 2022 | 36560509 | PubTator, text mining | PubMed |
| Unconventional Myosins from Caenorhabditis elegans as a Probe to Study Human Orthologues. | Biomolecules | 2022 | 36551317 | PubTator, text mining | PubMed |
| Longitudinal study of teacher acceptance of mobile virtual labs. | Educ Inf Technol (Dordr) | 2022 | 36532789 | PubTator, text mining | PubMed |
| SARS-CoV-2 epitopes inform future vaccination strategies. | Front Immunol | 2022 | 36505475 | PubTator, text mining | PubMed |
| Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer. | Cancers (Basel) | 2022 | 36497339 | PubTator, text mining | PubMed |
A reversible cell penetrating peptide-cargo linkage allows dissection of cell penetrating peptide- and cargo-dependent effects on internalization and identifies new functionalities of putative endolytic peptides. | Front Pharmacol | 2022 | 36479201 | PubTator, text mining | PubMed |
| Planar aggregation of the influenza viral fusion peptide alters membrane structure and hydration, promoting poration. | Nat Commun | 2022 | 36470871 | PubTator, text mining | PubMed |
| [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity. | JACS Au | 2022 | 36465552 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. | Virol J | 2022 | 36463213 | PubTator, text mining | PubMed |
| Real-time chirality transfer monitoring from statistically random to discrete homochiral nanotubes. | Nat Commun | 2022 | 36450720 | PubTator, text mining | PubMed |
| Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer. | Cancers (Basel) | 2022 | 36428639 | PubTator, text mining | PubMed |
| Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus. | Viruses | 2022 | 36423139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64005/papers?page=11